| Christine M Sutton, PA | |
|
1020 E Ogden Ave, Ste 115, Naperville, IL 60563 | |
| (630) 717-8707 | |
| Not Available |
| Full Name | Christine M Sutton |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 1020 E Ogden Ave, Naperville, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083991939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 085004167 (Illinois) | Secondary |
| 363AM0700X | Physician Assistant - Medical | 085004167 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward Hospital | Naperville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward Health Ventures | 4284531484 | 510 |
News Archive
This is the first large-scale analysis of what the authors call the "compensatory conscientiousness effect," the boost in health reported by those with conscientious spouses or romantic partners. The study appears this month in Psychological Science .
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
According to a new analysis of 36 different types of tumors and blood cancers that affect both sexes, men are more likely than women to get and die of cancer. The report shows that leukemia and cancers of the colon and rectum, pancreas, and liver killed about one and a half to two times as many men as women in the U.S. over a 30-year period. Lung cancer killed nearly two and a half times as many men during that time. According to the American Cancer Society men have about a 1 in 2 chance of developing cancer at some point in their lives, compared with women, who have a 1 in 3 chance.
The U.S. Food and Drug Administration today unveiled a report outlining the agency's plans to advance regulatory science through its Regulatory Science Initiatie.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine M Sutton, PA 1860 Payshere Cir, Chicago, IL 60674-0001 Ph: () - | Christine M Sutton, PA 1020 E Ogden Ave, Ste 115, Naperville, IL 60563 Ph: (630) 717-8707 |
News Archive
This is the first large-scale analysis of what the authors call the "compensatory conscientiousness effect," the boost in health reported by those with conscientious spouses or romantic partners. The study appears this month in Psychological Science .
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
According to a new analysis of 36 different types of tumors and blood cancers that affect both sexes, men are more likely than women to get and die of cancer. The report shows that leukemia and cancers of the colon and rectum, pancreas, and liver killed about one and a half to two times as many men as women in the U.S. over a 30-year period. Lung cancer killed nearly two and a half times as many men during that time. According to the American Cancer Society men have about a 1 in 2 chance of developing cancer at some point in their lives, compared with women, who have a 1 in 3 chance.
The U.S. Food and Drug Administration today unveiled a report outlining the agency's plans to advance regulatory science through its Regulatory Science Initiatie.
› Verified 7 days ago
Jennifer Lynn Bren, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2940 Rollingridge Rd, Suite 201, Naperville, IL 60564 Phone: 630-967-6000 | |
Carla R. Nutter, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 10 Martin Ave Ste 225, Naperville, IL 60540 Phone: 303-355-5633 Fax: 630-355-5215 | |
Alexa Childs, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 801 S Washington St, Naperville, IL 60540 Phone: 630-527-3000 | |
Jessica Waters, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1460 Bond St, Naperville, IL 60563 Phone: 630-859-0120 | |
Poojan Nilesh Patel, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 100 Spalding Dr Ste 300, Naperville, IL 60540 Phone: 630-527-3200 | |
Aimee Naleway, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4003 S Route 59, Naperville, IL 60564 Phone: 888-693-6437 Fax: 630-432-6667 | |
Aiman Khan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 636 Raymond Dr Ste 107, Naperville, IL 60563 Phone: 630-416-2300 |